ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Aeglea BioTherapeutics Inc

Aeglea BioTherapeutics Inc (AGLE)

12.01
0.00
(0.00%)
Closed November 11 4:00PM
12.01
0.00
( 0.00% )
Pre Market: 7:00PM

Aeglea BioTherapeutics Inc Financial Summary

The current AGLE market cap is 48.63M. The company's latest EPS is USD -83.6725 and P/E is -0.14.

Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 688k0000
Operating Income -159.25M-32.95M-47.75M-47.77M-44.15M
Net Income -217.08M-40.16M-63.13M-43.86M-38.84M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0018.74M2.33M886k
Operating Income -80.33M-81.48M-65.65M-84.78M-258.75M
Net Income -78.25M-80.89M-65.8M-83.82M-338.79M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 243.53M207.27M341.86M487.6M436.07M
Total Liabilities 253.58M65.56M73.29M81.93M61.68M
Total Equity -207.37M-245.4M184.02M152.27M374.39M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 83.18M161.62M109.93M71.14M341.86M
Total Liabilities 23.1M21.79M25.99M20.84M73.29M
Total Equity 60.08M139.83M83.94M50.31M184.02M
Quarter End Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -34.28M-68.87M-99.91M-28.54M-90.79M
Investing 24.51M-73.12M-108.39M-104.96M-225.48M
Financing 210M197.47M361.08M172.17M172.53M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -65.69M-75.78M-53.72M-80.14M-99.91M
Investing -1.74M-7.6M-22.62M57.01M-108.39M
Financing 65.72M154.51M1.39M42.68M361.08M
Market Cap 48.63M
Price to Earnings Ratio -0.14
Price to Sales Ratio 54.89
Price to Cash Ratio 0.26
Price to Book Ratio 0.18
Dividend Yield -

Share Statistics

Shares Outstanding 4.05M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) 2.8 (20%)

Company Info

Company Name Aeglea BioTherapeutics Inc
Address 1521 concord pike
wilmington, delaware 19803
Website https://www.spyre.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock